Abstract
Background: India reports the highest number of cases of tuberculosis (TB) in India. Patients with TB employ negative financial coping mechanisms (dissaving) to make up for the costs of care. Our objectives were to explore the dissaving employed and enablers perceived by patients with TB-HIV, patients with TB-diabetes, and program managers of TB.
Methods: We conducted qualitative in-depth interviews among eight TB-HIV patients, eight TB-diabetes patients, and seventeen program managers of TB in the Bhavnagar region (western part of India). An interview guide focusing on the coping strategies and enablers was used. Interviews were audio-recorded, transcribed, and analyzed using thematic analysis (codes and categories).
Results: Borrowing money, taking a loan on interest, selling jewellery, taking up employment by the spouse, and mortgaging assets were the negative financial coping strategies employed by patients with TB-HIV co-infection/ TB-diabetes comorbidity. Free diagnosis, free treatment, accessible health facilities, support from health workers, bi-directional screening, and collaborative integration were some of the enablers perceived by patients and program managers.
Conclusions: Even in settings with a decentralized “free” model of TB care, patients with co-prevalent TB-HIV/ TB-diabetes employ dissaving to offset the costs of care. The cash transfer scheme for patients with TB should be realigned to meet the financial protection targets of zero catastrophic costs by the year 2030.
Subject
Public Health, Environmental and Occupational Health,Medicine (miscellaneous),Epidemiology
Reference26 articles.
1. World Health Organization. Global Tuberculosis Report 2021 [Internet]. Geneva: World Health Organization; 2021. Available from: https://apps.who.int/iris/rest/bitstreams/1379788/retrieve
2. World Bank Group. Poverty & Equity Brief: South Asia - India [Internet]. 2020 [cited 2022 Jul 2]. Available from: https://databank.worldbank.org/data/download/poverty/33EF03BB-9722-4AE2-ABC7-AA2972D68AFE/Global_POVEQ_IND.pdf
3. Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, et al. Defining Catastrophic Costs and Comparing Their Importance for Adverse Tuberculosis Outcome with Multi-Drug Resistance: A Prospective Cohort Study, Peru. Ruger JP, editor. PLoS Med [Internet]. 2014 Jul 15;11(7):e1001675. Doi: https://doi.org/10.1371/journal.pmed.1001675 PMid:25025331 PMCid:PMC4098993
4. Ghazy RM, El Saeh HM, Abdulaziz S, Hammouda EA, Elzorkany AM, Khidr H, et al. A systematic review and meta-analysis of the catastrophic costs incurred by tuberculosis patients. Sci Rep [Internet]. 2022;12(1):1-16. Doi: https://doi.org/10.1038/s41598-021-04345-x PMid:35017604 PMCid:PMC8752613
5. Rupani MP, Cattamanchi A, Shete PB, Vollmer WM, Basu S, Dave JD. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India. Infect Dis Poverty [Internet]. 2020 Dec 19;9(1):144. Available from: https://idpjournal.biomedcentral.com/articles/10.1186/s40249-020-00760-w Doi: https://doi.org/10.1186/s40249-020-00760-w PMid:33076969 PMCid:PMC7574230
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献